O
28
8
AVGO
64
-5
CHRW
60
3
CTSH
49
2
ADT
41
-4
TDC
57
-5
KR
40
-2
STZ
30
-3
PDCO
77
-2
WY
31
-3
CCL
48
-2
HBI
65
3
PYPL
60
-4
NEE
39
-2
LMT
22
-5
PBI
33
-7
FAST
41
4
CCI
26
-2
SYK
42
-2
PRU
44
5
O
28
8
AVGO
64
-5
CHRW
60
3
CTSH
49
2
ADT
41
-4
TDC
57
-5
KR
40
-2
STZ
30
-3
PDCO
77
-2
WY
31
-3
CCL
48
-2
HBI
65
3
PYPL
60
-4
NEE
39
-2
LMT
22
-5
PBI
33
-7
FAST
41
4
CCI
26
-2
SYK
42
-2
PRU
44
5
Financhill
Back

scPharmaceuticals 10K Form

Sell
15

SCPH
scPharmaceuticals

Last Price:
$3.56
Seasonality Move:
8.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-13 10Q SCPH/scPharmaceuticals Quarterly
2020-05-12 10Q SCPH/scPharmaceuticals Quarterly
2020-03-24 10K SCPH/scPharmaceuticals Annual
2019-11-12 10Q SCPH/scPharmaceuticals Quarterly
2019-08-07 10Q SCPH/scPharmaceuticals Quarterly
2019-05-08 10Q SCPH/scPharmaceuticals Quarterly

Receive SCPH News And Ratings

See the #1 stock for the next 7 days that we like better than SCPH

SCPH Financial Statistics

Sales & Book Value

Annual Sales: $13.6M
Cash Flow: $-17.4M
Price / Cash Flow: 0
Annual Sales: $0.61
Price / Book: 5.79

Profitability

EPS (TTM): -1.90000
Net Income (TTM): $-80.1M
Gross Margin: $9.8M
Return on Equity: -265.48%
Return on Assets: -85.31%

scPharmaceuticals Earnings Forecast

Key scPharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 2 years for SCPH is 71.96%.
  • The Selling, General & Administrative Expenses for SCPH have been equal to 392.62% of Gross Profit Margin.
  • The Research & Development expenses have been 86.88% of Revenue.
  • The Interest Expense is -14.82% of Operating Income.
  • The Net Earning history of SCPH is -403.22% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

scPharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SCPH
CUSIP: 810648
Website: scpharmaceuticals.com

Debt

Debt-to-Equity Ratio: 1.66
Current Ratio: 8.08
Quick Ratio: 6.6

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 11.29

SCPH Technical Analysis vs Fundamental Analysis

Sell
15
scPharmaceuticals (SCPH) is a Sell

Is scPharmaceuticals a Buy or a Sell?

  • scPharmaceuticals stock is rated a Sell
    The current scPharmaceuticals [SCPH] share price is $3.56. The Score for SCPH is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.